2021
DOI: 10.1016/j.jgr.2019.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Effect of coadministration of enriched Korean Red Ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(26 citation statements)
references
References 34 publications
0
24
0
Order By: Relevance
“…Besides, a randomized, placebo‐controlled, double-blind study in 20 type 2 diabetic patients (mean age: 51.5 ± 1.9 years) observed about 45% reduction in HOMA-IR in the group which was given P. ginseng supplementation compared to 12% reduction for the placebo group ( 146 ). Moreover, combinatory administration of Panax ginseng and Panax quinquefolius in a 12 week long randomized controlled trial on 80 type 2 diabetic subjects (49 were male and 31 were female) reduced another glycemic control parameter, namely HbA1c by −0.35 ± 0.1% along with blood lipid parameters (total cholesterol, LDL-C, triglycerides) and 24-hour systolic blood pressure without causing any side effects ( 147 ).…”
Section: Panax Ginseng C a Meyermentioning
confidence: 99%
“…Besides, a randomized, placebo‐controlled, double-blind study in 20 type 2 diabetic patients (mean age: 51.5 ± 1.9 years) observed about 45% reduction in HOMA-IR in the group which was given P. ginseng supplementation compared to 12% reduction for the placebo group ( 146 ). Moreover, combinatory administration of Panax ginseng and Panax quinquefolius in a 12 week long randomized controlled trial on 80 type 2 diabetic subjects (49 were male and 31 were female) reduced another glycemic control parameter, namely HbA1c by −0.35 ± 0.1% along with blood lipid parameters (total cholesterol, LDL-C, triglycerides) and 24-hour systolic blood pressure without causing any side effects ( 147 ).…”
Section: Panax Ginseng C a Meyermentioning
confidence: 99%
“…Many clinical studies have investigated the potential protective effects of ginseng on cardiometabolic indices among individuals with diabetes; however, the results have been inconsistent [1,5,[21][22][23][24][25]. Some studies documented improved levels of anthropometric indices [1], glucose-related markers [26,27], lipid profile components [5], blood pressure [28], and inflammatory markers [21] following ginseng consumption, whereas others indicated null effects [12,22,29,30].…”
Section: Introductionmentioning
confidence: 99%
“…Many clinical studies have investigated the potential protective effects of ginseng on cardiometabolic indices among individuals with diabetes; however, the results have been inconsistent [1,5,[21][22][23][24][25]. Some studies documented improved levels of anthropometric indices [1], glucose-related markers [26,27], lipid profile components [5], blood pressure [28], and inflammatory markers [21] following ginseng consumption, whereas others indicated null effects [12,22,29,30]. Furthermore, previous systematic reviews and meta-analyses of randomized controlled trials (RCTs) on ginseng supplementation have only covered certain cardiometabolic indicators in various health conditions [19,[31][32][33][34][35][36].…”
Section: Introductionmentioning
confidence: 99%
“…It has been utilized in functional foods, herbal medicine, and so on. American ginseng possesses various medicinal properties, such as antihyperglycemic [ 5 , 6 ], immunologic [ 7 , 8 ], cardiovascular [ 9 , 10 ], antioxidant [ 11 , 12 ], and anticancer effects [ 13 ], as well as improved neurocognitive function. Most of these medicinal effects are attributed to its main constituents, polysaccharides and ginsenosides [ 14 ].…”
Section: Introductionmentioning
confidence: 99%